Drug Patents owned by Medicure
1. List of Aggrastat drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6770660 | MEDICURE | Method for inhibiting platelet aggregation |
May, 2023
(a month from now) | |
Drugs and Companies using TIROFIBAN HYDROCHLORIDE ingredient
Market Authorisation Date: 14 May, 1998
Treatment: A dosing regimen of aggrastat (tirofiban hydrochloride)(25mcg/kg followed by 0.15mcg/kg/min infusion) to reduce the rate of thrombotic coronary events associated with acute coronary syndrome (acs) in ...
Dosage: INJECTABLE;INJECTION; SOLUTION;INJECTION
AGGRASTAT family patents
8
United States
1
Japan
1
Canada
1
Australia
1
European Union
2. List of Zypitamag drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8829186 | MEDICURE | Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof |
Jan, 2031
(7 years from now) | |
Drugs and Companies using PITAVASTATIN MAGNESIUM ingredient
Market Authorisation Date: 14 July, 2017
Treatment: NA
Dosage: TABLET;ORAL
ZYPITAMAG family patents
3
United States
2
India
1
Japan
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic